JPH08173554A - Skin contact therapeutic apparatus - Google Patents

Skin contact therapeutic apparatus

Info

Publication number
JPH08173554A
JPH08173554A JP34084194A JP34084194A JPH08173554A JP H08173554 A JPH08173554 A JP H08173554A JP 34084194 A JP34084194 A JP 34084194A JP 34084194 A JP34084194 A JP 34084194A JP H08173554 A JPH08173554 A JP H08173554A
Authority
JP
Japan
Prior art keywords
skin
conductive
mineral
conductive mineral
skin contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP34084194A
Other languages
Japanese (ja)
Other versions
JP3748278B2 (en
Inventor
Masahisa Muroki
政久 室木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PORITORONIKUSU KK
Polytronics Inc
Original Assignee
PORITORONIKUSU KK
Polytronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PORITORONIKUSU KK, Polytronics Inc filed Critical PORITORONIKUSU KK
Priority to JP34084194A priority Critical patent/JP3748278B2/en
Publication of JPH08173554A publication Critical patent/JPH08173554A/en
Application granted granted Critical
Publication of JP3748278B2 publication Critical patent/JP3748278B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE: To provide a metal positive electrode/semiconductor negative electrode type bioelectric cell skin contact therapeutic apparatus which is prevented from causing a skin damage by electrically connecting a pair of conductive minerals, in which relationship of standard single electrode potential is specifically determined, to each other at respective skin non-contact portions via a protective resistor having a specific resistance value. CONSTITUTION: A first conductive meneral 1 is formed of a brass disk and a protrusion Ir is formed at its central part. Gold plating is applied to a surface having the protrusion Ir , and the protrusion Ir constitutes a skin contact part. In this case, a first skin contact substance is 18-karats gold. A second conductive mineral 2 is formed of a zinc-made ring and a surface thereof is heat treated to form a specified zinc oxide coating film. A second skin contact substance formed of the second conductive mineral 2 is formed of a zinc oxide of an n-type semiconductor, and standard single electrode potential thereof is made lower than that of the first skin contact substance. Both the conductive minerals 1, 2 are electrically connected to each other a protective resistor 3 of resistance 0.1-50MΩ at a skin non-contact portion. As the protective resistor 3, carbon powder dispersed in an epoxy resin, for example, can be used.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮接治療具に関する。
特に、肩コリや腰痛等の不定愁訴解消に効果のある皮接
治療具に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin care device.
In particular, the present invention relates to a skin treatment device which is effective in resolving indefinite complaints such as shoulder stiffness and back pain.

【0002】[0002]

【従来の技術】近年、生活様態の複雑化や高齢者の増加
に伴って、慢性的なコリや痛みに悩まされる患者が増加
している。その主要な原因は、筋肉や神経の局部的疲労
によると言われている。筋肉や神経の疲労をもたらす原
因やそのは、各人によって異なり、またその程度も異な
るが、スポーツによる筋肉疲労のような一過性のもので
はなく原因が日常生活の中にある場合には、慢性疾患に
なることが多い。コリや痛みが重度の場合は、病院にお
ける物療や鍼灸治療に頼らざるを得ないが、比較的軽度
であっても日常生活では、不快感(不定愁訴)を伴なう
ので、簡便な治療方法の開発が求められている。
2. Description of the Related Art In recent years, the number of patients suffering from chronic stiffness and pain has increased with the complexity of lifestyles and the increase in the number of elderly people. The main cause is said to be local fatigue of muscles and nerves. The causes and causes of muscle and nerve fatigue vary from person to person and to a different extent, but if the cause is in daily life rather than a transient one such as muscle fatigue from sports, Often becomes a chronic disease. If stiffness and pain are severe, you will have to rely on physical therapy or acupuncture treatment at the hospital, but even a relatively mild case causes discomfort (indefinite complaints) in daily life, so a simple treatment method Development is required.

【0003】従来、家庭におけるコリや痛みの治療具と
して、パップ剤や温灸、金属粒や磁気治療具、低周波治
療器などが開発、市販されている。これらはいずれも患
部の血行を促進し、以って局部的に滞留した老廃物質を
浄化しようとする狙いで開発されている。このうちパッ
プ剤や温灸、磁気治療具は血管拡張による効果を、また
低周波治療器は規則的に筋肉を緊張・弛緩させることに
よる物療効果を、更に金属粒は東洋医学における経絡・
経穴治療を目的としたものである。これに対して本発明
者は、皮接時に生体電池が形成されて弱い直流起電力の
通電刺激で筋肉や神経の疲労を癒し得るイオン浸透器を
開発した(特許第1388949号、特許第14273
60号、特許第1631137号、実用新案19221
66号など)。これらのイオン浸透器は、コリや痛みの
治療に対して前記した家庭用治療具以上の効果を発揮し
ている。
Conventionally, poultices, hot moxibustion, metal particles, magnetic therapy tools, low-frequency therapy devices, etc. have been developed and marketed as tools for treating stiffness and pain at home. All of these have been developed with the aim of promoting blood circulation in the affected area and thereby purifying locally accumulated waste substances. Of these, poultices, hot moxibustion, and magnetic therapy devices have the effect of vasodilation, low-frequency therapy devices have the physical effect of regularly tightening and relaxing the muscles, and metal particles have the meridian and oriental medicine in Oriental medicine.
It is intended for acupuncture treatment. On the other hand, the present inventor has developed an ion infiltrator capable of healing fatigue of muscles and nerves by a weak direct current electromotive force that forms a bio-cell during skin contact (Japanese Patent Nos. 1388949 and 14273).
60, Patent No. 1631137, Utility Model 19221
No. 66). These ion infiltrators are more effective than the above-mentioned household treatment tools for treating stiffness and pain.

【0004】前記のイオン浸透器と同様、生体電池の形
成を目的とする治療具として、外部回路短絡型の異種金
属組合せによるものが開示されている(例えば、実開昭
57−103743号公報)。本発明者のイオン浸透器
は、半導体結晶とこれより標準単極電位の高い金属とを
導電接続して皮接するもので、前記異種金属組合せの皮
接具とは構成と共に、よってきたる効果を異にする。図
2は、この二つの皮接具の違いを説明するための図であ
る。図2(A)は、金属正極/半導体負極の組合せによ
る生体電池の原理を示している。即ち、この生体電池で
は、半導体負極から金属正極へ流出した電子が、金属正
極から電解質である皮膚内へ流入して還元作用(例えば
体内に分布する鉄イオンについては、Fe3++e→F
2+)を惹起すると同時に、電子の不足した半導体負
極で発生する正孔が皮接面で発生するショットキー障壁
の内部電界によってドリフトして半導体結晶の皮接面に
集中し、皮接面の半導体原子をイオン化する。内部電界
は陽イオン及び正孔を半導体負極から引き剥す作用をす
るので、解離した半導体イオンが正孔と共に皮膚内に浸
透する。皮膚内では正孔が酸化作用(例えばFe3+
→Fe2+)を生ずる。また、皮接面のショットキ
ー障壁は、皮膚内から電子や陰イオンが半導体内に流入
するのを阻止する働きを示すので、負極の前記参加作用
(陽イオンの剥離と正孔の流失)が安定して継続し、起
電力が長時間に亙って安定に続くのである。
Similar to the above-mentioned ion infiltrator, a therapeutic tool for forming a bio-cell is disclosed which uses a combination of different types of external circuit short-circuiting metals (for example, Japanese Utility Model Laid-Open No. 57-103743). . The ion infiltrator of the present inventor conducts a skin contact by conductively connecting a semiconductor crystal and a metal having a higher standard single pole potential than the semiconductor crystal, and is different from the skin contact tool of the above-mentioned dissimilar metal combination in the structure and the subsequent effect. To FIG. 2 is a diagram for explaining the difference between the two skin-jointing tools. FIG. 2 (A) shows the principle of a bio-cell using a combination of a metal positive electrode / semiconductor negative electrode. That is, in this bio-cell, the electrons flowing out from the semiconductor negative electrode to the metal positive electrode flow into the skin, which is the electrolyte, from the metal positive electrode and undergo a reducing action (for example, for iron ions distributed in the body, Fe 3+ + e → F).
e 2+ ) and at the same time, holes generated in the semiconductor negative electrode lacking electrons drift due to the internal electric field of the Schottky barrier generated in the skin contact surface and concentrate on the skin contact surface of the semiconductor crystal. Ionize semiconductor atoms. Since the internal electric field acts to separate positive ions and holes from the semiconductor negative electrode, the dissociated semiconductor ions penetrate into the skin together with the holes. In the skin, holes oxidize (eg Fe 3 ++
h + → Fe 2+ ) is produced. Further, the Schottky barrier on the skin-contacting surface has a function of preventing electrons and anions from flowing into the semiconductor from the inside of the skin, so that the above-described participation action of the negative electrode (exfoliation of cations and washout of holes) occurs. It continues to be stable, and the electromotive force is stable for a long time.

【0005】一方,異種金属の組合せ(例えばCu/Z
nの組合せ)による皮接具においては、図2(B)で示
すように電子親和力xのより大きな金属Aに向かって電
子が金属Bから流出するため、金属Bでは電子が不足し
てプラスに耐電する(x>x)。しかし、金属Bは
皮接面でショットキー障壁を形成することはないので、
皮膚面或はその近傍に分布する水分由来のマイナスイオ
ンOHが金属Bの表面層に浸入して速やかに吸着化合
する。この結果、金属Bの皮接面には水酸化物が形成さ
れる。例えば、Cu/Znの組合せでは、金属Bである
Znの皮接面で、 Zn+20H→Z(OH) なる反応を生じる。卑金属のこれら水酸化物は一殿に絶
縁性であり、そのため金属Bの表面が高抵抗化して起電
力が不安定になり、やがて水酸化物層厚の増大に伴って
発電が停止する。これが表面の不動態化現象である。
On the other hand, a combination of different metals (eg Cu / Z
2B, the electrons flow out from the metal B toward the metal A having a larger electron affinity x, so that the metal B lacks electrons and becomes positive. Withstand electricity (x A > x B ). However, since metal B does not form a Schottky barrier at the skin contact surface,
Negative ions OH derived from water distributed on or near the skin surface penetrate into the surface layer of metal B and are rapidly adsorbed and combined. As a result, a hydroxide is formed on the skin contact surface of the metal B. For example, in the combination of Cu / Zn, a reaction of Zn + 20H → Z (OH) 2 occurs at the skin contact surface of Zn which is the metal B. These base metal hydroxides are all insulative, so that the surface of the metal B has a high resistance and the electromotive force becomes unstable. Eventually, power generation stops as the hydroxide layer thickness increases. This is the surface passivation phenomenon.

【0006】また、金属正極/半導体負極の組み合わせ
では、図2(A)で示す様に、正極下の還元生成イオン
(例えばFe2+)と負極下の酸化生成イオン(例えば
Fe3+)とが相互拡散して、図示した向きに皮膚内の
実効的なイオン電荷の流れを作り、各領域のイオン不足
分を補うため、いわゆる電池の逆起電力は起きにくい。
これに対して、異種金属の組合せでは、図2(B)に示
すように、正極下で発生した還元生成イオン(例えばF
2+)の元になる被還元イオン(例えばFe3+)の
不足分が半導体負極下から補われないので、被還元イオ
ンが次第に不足して逆起電力が発生しやすいという欠点
もある。前記した説明のように、外部回路を短絡した金
属正極/半導体負極形生体電池は、皮接後に安定した酸
化・還元作用、したがって安定した起電力を示すため、
長時間の皮接によっても劣化が少なく、実用的なコリ、
痛みの治療具として高い治療効果をあげている。
Further, in the combination of the metal positive electrode / semiconductor negative electrode, as shown in FIG. 2 (A), the reduction product ions (eg Fe 2+ ) under the positive electrode and the oxidation product ions (eg Fe 3+ ) under the negative electrode interact with each other. Since it diffuses to form an effective flow of ionic charges in the skin in the direction shown in the figure and compensates for the ion deficiency in each region, so-called back electromotive force of the battery is unlikely to occur.
On the other hand, in the case of the combination of different metals, as shown in FIG. 2B, reduction product ions (for example, F
Since the shortage of the reducible ions (for example, Fe 3+ ) that is the source of e 2+ ) is not compensated from below the semiconductor negative electrode, there is also a drawback that the reducible ions gradually become insufficient and a counter electromotive force is easily generated. As described above, the metal positive electrode / semiconductor negative electrode type biological battery with the external circuit short-circuited exhibits a stable oxidation / reduction action after skin contact, and thus a stable electromotive force.
Practical stiffness, with little deterioration even after long-term skin contact
It is highly effective as a treatment tool for pain.

【0007】[0007]

【従来技術の問題点】図2(A)を用いて動作を説明し
た金属正極/半導体負極形生体電池は、安定した起電力
によって持続的に筋肉及び神経系組織に通電刺激を与
え、効果的にコリや痛みを解消させることが出来る。慢
性的なコリや痛みの原因は、通常患者各人の日常生活の
中にあるので、一時的に治療効果が発揮されても治療行
為を中止すれば、再びコリや痛みが戻ることが多い。そ
こで前記した生体電池も長期連用されることが多い。と
ころで前記生体電池の理論発生起電力は、金属正極と半
導体負極の材料組合せ及び皮膚内における様々な酸化
(負極下)・還元(正極下)反応の化学エネルギー和に
よって決まる。したがって、同じ人が同じ場所に皮接す
る場合には、起電力、したがって通電刺激値を材料組合
せによって調節することが出来る。
[Problems of the prior art] The metal positive electrode / semiconductor negative electrode type biological battery whose operation has been described with reference to FIG. 2 (A) is effective because a stable electromotive force continuously applies electrical stimulation to muscle and nervous system tissues. It can eliminate stiffness and pain. The cause of chronic stiffness and pain is usually in the daily life of each patient, so even if the therapeutic effect is temporarily exerted, stiffness and pain often return again if the treatment is stopped. Therefore, the above-mentioned bio battery is often used for a long period of time. The theoretical electromotive force of the bio-cell is determined by the material combination of the metal positive electrode and the semiconductor negative electrode and the sum of chemical energy of various oxidation (under negative electrode) / reduction (under positive electrode) reactions in the skin. Therefore, when the same person is skin-contacted at the same place, the electromotive force, and thus the electrical stimulation value can be adjusted by the material combination.

【0008】理論発生起電力を電圧で表わしてEとす
る時、図1のような皮接時閉回路を考えると、金属正極
/半導体負極間に取出される外部起電力Eは、 E≒(RC1+RC2)I=E−RI (1) となる。ここで、Rは皮膚内の電極間インピーダンス
即ち生体電池の内部抵抗(以下単に「皮膚インピーダン
ス」という。)、またRC1、RC2は各電極と皮膚と
の間の接触抵抗、Rは両接触抵抗RC1、RC2
和、Iは回路電流である。前記したコリと痛みを解消す
る治療効果は、生体電池の電流刺激によって生ずると考
えられるので、強い治療効果を得るには電流Iを大とす
れば良い。電流Iは次式で与えられる。そして、一般に
C2>>RC1である。
When the theoretically generated electromotive force is represented by voltage and is E T , the external electromotive force E extracted between the metal positive electrode and the semiconductor negative electrode is E≈ become (R C1 + R C2) I = E T -R S I (1). Here, R S is the impedance between electrodes in the skin, that is, the internal resistance of the bio-cell (hereinafter simply referred to as “skin impedance”), R C1 and R C2 are the contact resistances between each electrode and the skin, and R S is The sum of the contact resistances R C1 and R C2 , I is the circuit current. It is considered that the above-mentioned therapeutic effect for relieving stiffness and pain is caused by current stimulation of the bio-battery, so the current I may be increased to obtain a strong therapeutic effect. The current I is given by the following equation. And, in general, R C2 >> R C1 .

【0009】[0009]

【数1】 [Equation 1]

【0010】高齢者は一般に皮膚の含水率が低く、従っ
て、接触抵抗R(RC1+RC2)、皮膚インピーダン
スRは、共に高くなる。皮膚インピーダンスRは、
金属正極/半導体負極間の距離を短縮することによっ
て、小さくすることが出来る。従って、高齢者や重症患
者には、高い理論発生起電力Eを与える材料組合せ、
及び皮接治療具のデバイス形状の工夫(皮膚インピーダ
ンスR、及び接触抵抗R(RC1+RC2)を低減
する工夫)を行えば効果的である。ところが、生体の皮
膚インピーダンスは極めて変化しやすい性質をもつ。特
に、本発明者らは、前記生体電池の適用試験の過程で、
生体電池の皮接通電によって筋肉、神経系組織が生理活
性化されると、皮膚インピーダンスが著しく低下する現
象を、独自に発見した。通常、皮膚インピーダンスR
は、10〜50MΩ/cm、両電極の接触抵抗R(=
C1+RC2)は、1〜15MΩ/cmであるが、前
記生体電池の皮接によってコリや痛みが緩解した患者の
皮接前後における皮接箇所の皮膚インピーダンスを測定
してみると、皮膚インピーダンスR、及び接触抵抗R
が、共に50〜95%程度低下していることが認めら
れた。これは、皮膚呼吸など新陳代謝の活性化によって
皮膚内のイオン導電度が局部的に高まったことに起因す
るものと考えられる。
The elderly generally have a low water content in the skin, and therefore the contact resistance R (R C1 + R C2 ) and the skin impedance R S are both high. The skin impedance R S is
It can be reduced by shortening the distance between the metal positive electrode / semiconductor negative electrode. Therefore, the elderly and the ill patients, the material combination which gives a high theoretical generating electromotive force E T,
It is effective to devise the device shape of the skin treatment device (to reduce the skin impedance R S and the contact resistance R C (R C1 + R C2 )). However, the skin impedance of a living body has a property that it is extremely easy to change. In particular, the present inventors, in the process of application test of the bio-cell,
We have uniquely discovered a phenomenon in which the skin impedance is significantly reduced when the muscle and nervous system tissues are physiologically activated by skin contact energization of a bio-cell. Usually the skin impedance R S
Is 10 to 50 MΩ / cm, and the contact resistance R C (=
R C1 + R C2 ) is 1 to 15 MΩ / cm, but the skin impedance at the skin contact site before and after the skin contact of the patient in which stiffness and pain are relieved by the skin contact of the biological battery is measured, and the skin impedance is R S and contact resistance R
It was confirmed that both C were reduced by about 50 to 95%. It is considered that this is because the ionic conductivity in the skin locally increased due to the activation of metabolism such as skin respiration.

【0011】理論発生起電力Eは基本的に変化しない
ので、式(1)によれば、生理活性化の結果、意図せざ
る皮膚内電流値Iの増加(2〜20倍の増加)がもたら
されることになる。このような大幅な電流値の増加は、
皮膚組織に対する過剰刺激をもたらす。したがって、皮
膚の弱い患者はアレルギー反応を起こし、発赤や掻疼感
を訴えることがある。つまり、コリや痛みの治療と引換
えに、皮膚損傷を引起こす場合が散見されたのである。
これに対しては、勿論、当初から理論発生起電力E
小さな組合せを選択すれば対処出来るが、理論発生起電
力Eが小さい組合せでは、通電効果が限定されるの
で、高齢者や重症患者には治療効果が薄くなるおそれが
ないではない。以上の問題点は、本発明者らによって、
独自に発見されたものである。
Since the theoretical electromotive force E T basically does not change, according to the equation (1), an unintended increase in the skin current value I (increase of 2 to 20 times) is caused as a result of physiological activation. Will be brought. Such a large increase in current value is
Causes excessive irritation to skin tissue. Therefore, patients with weak skin may have an allergic reaction and may complain of redness and scratching. In other words, there were occasional cases where skin damage was caused in exchange for treatment of stiffness and pain.
This can of course be dealt with by selecting a combination with a small theoretical electromotive force E T from the beginning, but with a combination with a small theoretical electromotive force E T , the energization effect is limited, so that the elderly and seriously ill Patients are not at risk of diminished therapeutic efficacy. The above problems are caused by the present inventors.
It was originally discovered.

【0012】[0012]

【発明の目的】それ故、本発明の第1の目的は、皮接中
に生理活性化して皮膚インピーダンスが低下しても、皮
膚損傷を起こす可能性の小さな金属正極/半導体負極形
生体電池皮接治療具を提供することにある。本発明の第
2の目的は、安価でディスボーサブルな生体電池形皮接
治療具を提供することにある。
SUMMARY OF THE INVENTION Therefore, a first object of the present invention is a metal positive electrode / semiconductor negative electrode type bioelectrical battery skin which is less likely to cause skin damage even when the skin impedance is lowered due to physiological activation during skin contact. It is to provide a treatment tool. It is a second object of the present invention to provide an inexpensive and disposable bio-cell skin treatment device.

【0013】[0013]

【目的を達成するための手段】前記の問題点を解決し、
前記の目的を達成するために、本発明による皮接治療具
は、第1の導電性鉱物(導電性鉱物A)1と、第2の導
電性鉱物(導電性鉱物B)2と、保護抵抗3とから成
り、前記第1の導電性鉱物1は、少なくともその皮接面
が、貴金属又はその合金から成る第1の皮接物質で構成
され、前記第2の導電性鉱物2は、少なくとも皮接面
が、n型半導体から成る第2の皮接物質で構成され、前
記第1の皮接物質と前記第2の皮接物質との組合せは、
前記第1の皮接物質の標準単極電位が前記第2の皮接物
質のそれよりも高く成るように、或は前記第2の皮接物
質の標準単極電位が前記第1の皮接物質のそれよりも低
く成るように選択され、前記第1の導電性鉱物1と前記
第2の導電性鉱物2とは、互いに近接して配置され、互
いの非皮接領域において、前記保護抵抗3を介して電気
的に接続され、前記保護抵抗3の抵抗値Rは、0.1〜
50MΩの範囲から、前記第1、第2の皮接物質の標準
単極電位間の差電位に応じて、適当な値が選択され、前
記第1の導電性鉱物1と前記第2の導電性鉱物2とは、
同時に皮接して用いられるものである。
[Means for achieving the object]
In order to achieve the above object, a skin treatment tool according to the present invention includes a first conductive mineral (conductive mineral A) 1, a second conductive mineral (conductive mineral B) 2, and a protective resistance. 3, the first conductive mineral 1 has at least a skin-contacting surface formed of a first skin-contacting material made of a noble metal or an alloy thereof, and the second conductive mineral 2 includes at least a skin-contacting material. The contact surface is composed of a second skin contact material made of an n-type semiconductor, and the combination of the first skin contact material and the second skin contact material is:
Such that the standard monopolar potential of the first skin contact material is higher than that of the second skin contact material, or the standard monopolar potential of the second skin contact material is the first skin contact material. The first conductive mineral 1 and the second conductive mineral 2 are selected so as to be lower than that of the substance, and the first conductive mineral 1 and the second conductive mineral 2 are arranged close to each other, and in the non-skin contact region of each other, the protective resistance is 3 is electrically connected, and the resistance value R of the protection resistor 3 is 0.1 to
An appropriate value is selected from the range of 50 MΩ according to the potential difference between the standard monopolar potentials of the first and second skin-contact substances, and the first conductive mineral 1 and the second conductive material are selected. What is Mineral 2?
It is used in skin contact at the same time.

【0014】前記第2の皮接物質は、安価でディスボー
ザブルな皮接具を実現するために、酸化物半導体であ
り、前記第2の導電性鉱物2は、これらの酸化物半導体
を構成する金属元素であることが好ましい。酸化物半導
体は、例えば酸化インジウムIn、酸化アンチモ
ンSb、酸化錫SnO、酸化亜鉛ZnO、酸素欠
損酸化アルミニウムAl3−x、酸素欠損酸化バナ
ジウムV5−xであり、第2の導電性鉱物2は、例
えば、酸化インジウムInに対してはインジウム
In、酸化アンチモンSbに対してはアンチモン
Sb等であることが好ましい。更に、前記保護抵抗3を
有する皮接具に、磁場を付与することが出来る。磁場の
強さは、皮接時に前記第1の皮接物質から皮膚内に注入
された電子、及び前記第2の皮接物質から皮膚内に注入
された正孔の運動に影響を及ぼす程度の強さとする。
The second skin contact material is an oxide semiconductor in order to realize an inexpensive and disposable skin contact tool, and the second conductive mineral 2 constitutes these oxide semiconductors. It is preferable that it is a metal element. The oxide semiconductor is, for example, indium oxide In 2 O 3 , antimony oxide Sb 2 O 5 , tin oxide SnO, zinc oxide ZnO, oxygen-deficient aluminum oxide Al 2 O 3-x , and oxygen-deficient vanadium oxide V 2 O 5-x . The second conductive mineral 2 is preferably indium In for indium oxide In 2 O 3 and antimony Sb for antimony oxide Sb 2 O 5, for example. Further, a magnetic field can be applied to the skin joint tool having the protection resistor 3. The strength of the magnetic field is such that the movement of the electrons injected into the skin from the first skin contact material and the holes injected into the skin from the second skin contact material during the skin contact is affected. Let it be strength.

【0015】[0015]

【作用】第1の導電性鉱物と第2の導電性鉱物とを保護
抵抗Rを介して、それぞれの非皮接部位で電気接続する
と、皮接時に図3のような閉回路が形成されるため、電
流Iが流れる。電流Iは、次の式(1)又は(2)で与
えられる。 (R+RC1+RC2)I=E−RI (1) I=E/(R+RC1+RC2) (2) ここに、皮膚インピーダンスR及び接触抵抗RC1
C2は可変である。そして、前記したように、RSR
>>RC2>>RC1である。そこで、保護抵抗Rを皮
膚インピーダンスR程度の大きさに選んでおくと、式
(2)から解る様に、生理活性化によって皮膚インピー
ダンスが1桁程低下したとしても、電流は、高々2倍程
度の増加にとどまり、過電流の通電による皮膚損傷をさ
けることが出来る。保護抵抗を、導電性フィラーを分散
した樹脂で形成し、第1の導電性鉱物と第2の導電性鉱
物とをこの樹脂で接着して外部回路接続とした正負極一
体化構造の生体電池はコンパクトであり、ワンタッチで
皮接出来る。
When the first conductive mineral and the second conductive mineral are electrically connected to each other through the protective resistance R at their non-skin contact portions, a closed circuit as shown in FIG. 3 is formed during the skin contact. Therefore, the current I flows. The current I is given by the following equation (1) or (2). (R + R C1 + R C2 ) I = E T −R S I (1) I = E T / (R S + R C1 + R C2 ) (2) Where, skin impedance R S and contact resistance R C1 ,
R C2 is variable. Then, as described above, R SR
>> R C2 >> R C1 . Therefore, if the protective resistance R is selected to have a size of about skin impedance R S, as can be seen from the formula (2), even if the skin impedance is reduced by about one digit due to physiological activation, the current is at most twice as high. It is only possible to prevent skin damage due to overcurrent. A biological battery having a positive and negative electrode integrated structure in which a protective resistance is formed of a resin in which a conductive filler is dispersed, and a first conductive mineral and a second conductive mineral are adhered by this resin to form an external circuit connection It is compact and can be skinned with one touch.

【0016】導電性鉱物Bの皮接面が酸化物半導体皮
膜、その基板がこの酸化物半導体を構成する金属元素で
形成されていると、皮接した時、前記したイオン浸透器
とは異なる振舞いをする。このような二重構造は、正極
金属甲(第1の皮接物質)より標準単極電位の低い(電
子親和力xの小さな)金属の表面を酸処理することによ
って、その表面に容易に厚さ1μm以下の金属酸化膜を
生成して得ることが出来る。一般に負極皮接面に形成さ
れる半導体内の高電界領域(ショットキー障壁に起因す
る空乏層領域)幅は、1〜3μmに達するので、前記の
ような金属酸化物半導体皮膜では、皮接時膜全体が空乏
層化していることになる。
When the skin contact surface of the conductive mineral B is formed of an oxide semiconductor film and the substrate thereof is formed of a metal element forming this oxide semiconductor, the skin behaves differently from the above-mentioned ion infiltrator. do. Such a double structure can be easily applied to the surface of a metal having a standard monopolar potential (small electron affinity x) smaller than that of the positive electrode metal shell (first skin contact material) by acid treatment. It can be obtained by forming a metal oxide film having a thickness of 1 μm or less. Generally, the width of the high electric field region (depletion layer region due to the Schottky barrier) in the semiconductor formed on the negative electrode skin contact surface reaches 1 to 3 μm. This means that the entire film is depleted.

【0017】図3に示したように、保護抵抗Rを入れて
電気的閉回路を形成すると、導電性鉱物B(負極)から
導電性鉱物A(正極)側へ熱的励起された電子eが流
出後内部電界に偏倚された正孔hは極めて速やかに皮
膚内に注入されるが、イオン浸透器のように半導体イオ
ン(S)がはく離して注入されることはない。これ
は、酸化物半導体においては金属と酸素のイオン結合力
が強いためである。むしろ、電子が流出して正に帯電す
ると、化学的に活性になり、金属の界面で酸化反応が促
進される。そして酸化物半導体の膜厚は速やかに本来の
高電界領域幅であるほぼ1〜3μmまで肥厚する。この
厚さ以降も酸化は徐々に進行し、共有結合性の半導体で
みられるような半導体イオンの皮接面からのはく離は、
ほとんど生起しないと考えられる。前記したような金属
の表面処理によって形成した酸化物半導体負極を用いれ
ば、生産コストが安くなり、安価でディスポーザブルな
皮接治療具の形成が可能となる。
As shown in FIG. 3, when a protective resistance R is inserted to form an electrically closed circuit, electrons e thermally excited from the conductive mineral B (negative electrode) to the conductive mineral A (positive electrode) side. The holes h + biased to the internal electric field after flowing out are injected into the skin very quickly, but the semiconductor ions (S + ) are not separated and injected unlike the ion infiltrator. This is because the oxide semiconductor has a strong ionic bond between metal and oxygen. Rather, when electrons flow out and become positively charged, they become chemically active and accelerate the oxidation reaction at the metal interface. Then, the film thickness of the oxide semiconductor rapidly increases to the original high electric field region width of approximately 1 to 3 μm. Oxidation gradually progresses even after this thickness, and the peeling of semiconductor ions from the skin-contact surface as seen in covalently bonded semiconductors is
It is thought that it hardly occurs. By using the oxide semiconductor negative electrode formed by the surface treatment of the metal as described above, the production cost is reduced, and it is possible to form an inexpensive and disposable skin treatment implement.

【0018】図4は、外部回路に保護抵抗Rを入れて正
極と負極とを電気接続した生体電池に、皮膚内に注入さ
れる電子及び正孔の運動が影響を受ける程度の磁場Hを
付与した場合の電子、正孔の動きを模式的に示したもの
である。図4において、生体電池電極(導電性鉱物A、
B)近傍の皮膚内には、一様な強度の磁場Hが図示した
方向(紙面の表側から裏側へ向かう方向)に印加されて
いるものとする。この時、正極下皮膚内に注入される電
子e及び負極下皮膚内に注入される正孔hは、電磁
力の作用を受けてそれぞれ図示した方向へ円運動をす
る。その半径rは、磁場強度Hに反比例し、皮膚内浸透
速度と電子質量(又は正孔質量)に比例する。この円運
動によって電子の還元作用及び正孔の酸化作用は、それ
ぞれの電極外部分へ広がるため、還元及び酸化生成物質
の局所濃度が薄まり、それだけ電池の逆起電力(減極作
用)が起きにくくなる。
In FIG. 4, a magnetic field H is applied to a bio-cell in which a protective resistance R is placed in an external circuit to electrically connect a positive electrode and a negative electrode to the movement of electrons and holes injected into the skin. 3 schematically shows movements of electrons and holes in the case of. In FIG. 4, a bio battery electrode (conductive mineral A,
B) It is assumed that a magnetic field H having a uniform strength is applied in the vicinity of the skin in the illustrated direction (direction from the front side to the back side of the paper surface). At this time, the electron e injected into the skin below the positive electrode and the hole h + injected into the skin below the negative electrode are circularly moved in the directions shown by the action of the electromagnetic force. The radius r is inversely proportional to the magnetic field strength H, and is proportional to the skin permeation rate and the electron mass (or hole mass). Due to this circular motion, the reducing action of electrons and the oxidizing action of holes spread to the outside of each electrode, so that the local concentration of reduction and oxidation products is reduced, and the counter electromotive force (depolarization action) of the battery is less likely to occur. Become.

【0019】[0019]

【実施例】本発明による皮接治療具の第1の実施例につ
いて説明する。図5は、同第1の実施例を皮接した状態
におけるその断面図である。図5において、1は第1の
導電性鉱物(導電性鉱物A)、2は第2の導電性鉱物
(導電性鉱物B)、3は保護抵抗、4は絆創膏又は貼着
布、5は皮膚である。第1の導電性鉱物(導電性鉱物
A)1は、直径6mm、厚さ2mmの真鍮円盤の一の面
の中央部に、高さ3mmの突起1を設け、該突起1
を有する面(の全部又は一部)に金メッキを施して成る
ものである。この場合、第1の皮接物質(皮接物質甲)
は、金(18K)である。そして、円盤1の中央部に位
置する突起1は皮接部を構成し、突起1を除く円盤
部分は導電部を構成する。第2の導電性鉱物(導電性鉱
物B)2は、外径6mm、内径2.5mm、厚さ1mm
の亜鉛製円環の表面を、酸処理によって、厚さ約0.5
μmの酸化亜鉛被膜に変えて成るものである。この場
合、第2の皮接物質(皮接物質乙)は、n形半導体の酸
化亜鉛である。保護抵抗3は、カーボン粉末を分散させ
た抵抗率10Ω/cmのエポキシ系樹脂を、前記第1
の導電性鉱物1の有突起面側の平坦部に、約1mmの厚
さで塗布してなるものである。保護抵抗3の抵抗値R
は、例えば10MΩ(皮接開始時の皮膚インピーダンス
にほぼ相当する値)である。保護抵抗3と第2の導電性
鉱物との接着は、前記樹脂が乾燥する前に、該樹脂の上
に第2の導電性鉱物を、図示したように、載置すること
によって、行われる。皮接治療具である生体電池の外部
回路は、保護抵抗Rを介して接続される。皮接する前に
前記第1の導電性鉱物1と第2の導電性鉱物2の両端で
測定した保護抵抗3の抵抗値は、約10MΩであった。
EXAMPLE A first example of the skin treatment device according to the present invention will be described. FIG. 5 is a cross-sectional view of the first embodiment in a state of being skin-contacted. In FIG. 5, 1 is a first conductive mineral (conductive mineral A), 2 is a second conductive mineral (conductive mineral B), 3 is protection resistance, 4 is a plaster or adhesive cloth, 5 is skin. Is. First conductive mineral (conductive mineral A) 1 has a diameter 6 mm, the central portion of one surface of the brass disc of thickness 2 mm, provided with a projection 1 r height 3 mm, the protrusion 1 r
The surface having (or all or part of) is plated with gold. In this case, the first skin contact material (skin contact material A)
Is gold (18K). The protrusion 1 r located at the center of the disc 1 constitutes a skin contact portion, and the disc portion excluding the protrusion 1 r constitutes a conductive portion. The second conductive mineral (conductive mineral B) 2 has an outer diameter of 6 mm, an inner diameter of 2.5 mm, and a thickness of 1 mm.
The surface of the zinc ring of
It is formed by changing to a zinc oxide coating of μm. In this case, the second skin contact substance (skin contact substance B) is n-type semiconductor zinc oxide. The protective resistor 3 is made of an epoxy resin in which carbon powder is dispersed and has a resistivity of 10 8 Ω / cm.
The conductive mineral 1 is applied to a flat portion on the protruding surface side in a thickness of about 1 mm. Resistance value R of protection resistor 3
Is, for example, 10 MΩ (a value substantially equivalent to the skin impedance at the start of skin contact). The protection resistor 3 and the second conductive mineral are adhered to each other by placing the second conductive mineral on the resin before the resin is dried, as shown in the figure. An external circuit of the biomedical battery, which is a skin treatment device, is connected via a protective resistance R. The resistance value of the protective resistor 3 measured at both ends of the first conductive mineral 1 and the second conductive mineral 2 before skin contact was about 10 MΩ.

【0020】第1の実施例の治験結果について説明す
る。前記の皮接治療具を紳創膏4で肩コリ患者の患部皮
膚5に圧接して、効き目を調べた。治験は、同一人に対
して3ケずつ同時に3日間貼着して行なった。被験者男
女75名に対してそれぞれ年代別に著効、有効、無効を
調べた結果を下記表1に示す。
The clinical trial results of the first embodiment will be described. The skin treatment device was pressed against the affected skin 5 of a shoulder stiffness patient with a gentle plaster 4 to examine the efficacy. The clinical trial was conducted by sticking three pieces to the same person at the same time for three days. Table 1 below shows the results of examining the effectiveness, effectiveness, and ineffectiveness of each of the 75 test subjects by age group.

【0021】[0021]

【表1】 [Table 1]

【0022】前記表1によれば、有効治験率、即ち著効
数と有効数とを加え、これを被験者総数で除した値は、
82.7%であることが解る。また、皮膚発赤や掻痒感
などの皮膚トラブルは、6.7%であることが解る。
According to Table 1 above, the effective clinical trial rate, that is, the value obtained by adding the excellent response number and the effective number and dividing this by the total number of subjects is
It turns out that it is 82.7%. Further, it can be seen that the skin trouble such as redness of skin and itchiness is 6.7%.

【0023】第1の実施例に係る、第1の対比例につい
て説明する。本発明との対比のために、第1の導電性鉱
物と第2の導電性鉱物とを、保護抵抗を介することな
く、導電性ペーストで直接的に接着し(従って外部回路
をほぼ短絡状態となし)、同様な被験テストを行なっ
た。この場合の有効治験率は、約85%で、第1の実施
例よりも若干高くなっていたが、皮膚トラブル数は、増
加し、約17%に達した。
The first contrast ratio according to the first embodiment will be described. For comparison with the present invention, the first conductive mineral and the second conductive mineral are directly bonded with a conductive paste without interposing a protective resistor (thus, the external circuit is substantially short-circuited). None), a similar test test was performed. The effective clinical trial rate in this case was about 85%, which was slightly higher than that in the first example, but the number of skin troubles increased to about 17%.

【0024】前記表1に示した若干の皮膚トラブルを詳
しく検討して見たところ、明らかに絆創膏3による軽度
の接触性皮膚炎の場合が大部分で、通電刺激による電極
周辺のトラブルは少なかった。これに対して、保護抵抗
Rを用いない場台(比較例)の皮膚トラブルの半数以上
(被験者の70%以上)は、通電刺激によるものと認め
られた。これを要するに、本発明の第1の実施例は、保
護抵抗3を導入することによって、通電刺激による皮膚
トラブルを、導入前に比べて、約1/4〜1/5に減少
させ得たことが明らかである。皮接部位における皮接治
療具の外部取出起電力は、0.6〜1.2ボルトに達し
ているが、保護抵抗3の抵抗値R、例えば約10MΩ
(皮接開始時の皮膚インピーダンスにほぼ相当する値)
が、生理活性化後の過電流を抑制しているのである。保
護抵抗3を導入したことの効果は明らかである。
When the skin troubles shown in Table 1 above were examined in detail, it was apparent that most of the cases were mild contact dermatitis due to the plaster 3 and that there were few troubles around the electrodes due to electrical stimulation. . On the other hand, more than half of the skin troubles (70% or more of the subjects) of the platform (comparative example) in which the protective resistance R was not used were recognized to be due to the electrical stimulation. In short, the first embodiment of the present invention can reduce the skin trouble due to the electrical stimulation to about 1/4 to 1/5 by introducing the protective resistance 3 as compared with the case before the introduction. Is clear. The external electromotive force of the skin treatment device at the skin contact portion reaches 0.6 to 1.2 volts, but the resistance value R of the protective resistor 3, for example, about 10 MΩ.
(A value approximately equivalent to the skin impedance at the start of skin contact)
However, it suppresses overcurrent after physiological activation. The effect of introducing the protection resistor 3 is clear.

【0025】本発明の皮接治療具の第2の実施例につい
て説明する。図6は、同第2の実施例の皮接治療具の構
成を示す図であって、同図(A)は上面図、(B)は側
面図である。図6において、1は第1の導電性鉱物(導
電性鉱物A)、2は第2の導電性鉱物(導電性鉱物
B)、3は保護抵抗、4は貼着布、5は皮膚である。第
1の導電性鉱物(導電性鉱物A)1は、錫の薄いフィル
ム表面に厚さ約2μmのロジウムがメッキされたもので
ある。第2の導電性鉱物2(導電性鉱物B)は、錫の薄
いフィルム表面に厚さ0.5μmの酸化錫薄膜が蒸着さ
れたものである。貼着布4は、適当な大きさ、例えば5
0×50mm位とする。その周縁部は皮接部位として
機能する。
A second embodiment of the skin care device of the present invention will be described. 6A and 6B are views showing the configuration of the skin treatment tool of the second embodiment, wherein FIG. 6A is a top view and FIG. 6B is a side view. In FIG. 6, 1 is a first conductive mineral (conductive mineral A), 2 is a second conductive mineral (conductive mineral B), 3 is a protective resistance, 4 is an adhesive cloth, and 5 is skin. . The first conductive mineral (conductive mineral A) 1 is a thin tin film surface plated with rhodium having a thickness of about 2 μm. The second conductive mineral 2 (conductive mineral B) is a thin film of tin on which a thin film of tin oxide having a thickness of 0.5 μm is deposited. The adhesive cloth 4 has an appropriate size, for example, 5
0x50mm 2nd place. The peripheral portion functions as a skin contact part.

【0026】保護抵抗3は、酸化インジウムIn
を分散させたポリイミド膜層から成っておって、その厚
みは、約0.5mm、抵抗率は10Ω/cm程度であ
る。この場合、保護抵抗値Rは、第1の導電性鉱物1と
第2の導電性鉱物2の間で、例えば0.5MΩ程度と成
る。保護抵抗3の層は、貼着布4の粘着面の非皮接領域
全面に、図示のように、塗布されて成る。保護抵抗3の
ポリイミド樹脂が乾燥する前に、帯状の第1の導電性鉱
物1及び第2の導電性鉱物2を、図示の如く、交互に且
つ規則正しい間隔をおいて、ポリイミド樹脂層に貼付す
る。第1の導電性鉱物1及び第2の導電性鉱物2の幅は
各々例えば2mm、間隔は例えば1mmとする。保護抵
抗3のポリイミド樹脂が乾燥すれば、完成品となる。
The protective resistor 3 is made of indium oxide In 2 O 3
Of a polyimide film layer having a thickness of about 0.5 mm and a resistivity of about 10 6 Ω / cm. In this case, the protection resistance value R is about 0.5 MΩ between the first conductive mineral 1 and the second conductive mineral 2. The layer of the protective resistor 3 is applied to the entire non-skin contact area of the adhesive surface of the adhesive cloth 4 as shown in the figure. Before the polyimide resin of the protection resistor 3 dries, the strip-shaped first conductive mineral 1 and the second conductive mineral 2 are attached to the polyimide resin layer alternately and at regular intervals as shown in the figure. . The width of each of the first conductive mineral 1 and the second conductive mineral 2 is, for example, 2 mm, and the interval is, for example, 1 mm. When the polyimide resin of the protection resistor 3 dries, it becomes a finished product.

【0027】第2の実施例の治験結果について説明す
る。皮接治療具を、貼着布4の皮接部位を利用して、コ
リや痛みのある箇所に皮接する。そうすると、n形酸化
錫→保護抵抗3→ロジウム→皮膚→n形酸化錫という電
気的閉回路が形成され、生体電池が発電し、通電刺激が
皮下組織に加えられる。この場合、保護抵抗値Rは、第
1の導電性鉱物1と第2の導電性鉱物2との間で、0.
5MΩ程度である。第2の実施例の皮接部位における外
部取出起電力は、0.3〜0.7ポルトであり、第1の
実施例の場合よりかなり低いため、保護抵抗値Rが1桁
低くても、治験における皮膚トラブルは、被験者の約5
%程度しか発生しないことが確かめられた。第2の実施
例の皮接治療具は、広い面積と柔軟性を有するため、一
枚で広い患部をカバー出来るという特色がある。この皮
接治療具を腰痛患者に適用した治験では、有効治癒率は
70%を越えた。
The clinical trial results of the second embodiment will be described. Using the skin-contacting treatment tool, a skin-contacting part of the patch cloth 4 is used to skin-contact a part having stiffness or pain. Then, an electrically closed circuit of n-type tin oxide → protective resistance 3 → rhodium → skin → n-type tin oxide is formed, the bio-cell generates electricity, and electrical stimulation is applied to the subcutaneous tissue. In this case, the protection resistance value R is 0..0 between the first conductive mineral 1 and the second conductive mineral 2.
It is about 5 MΩ. The externally extracted electromotive force at the skin contact portion of the second embodiment is 0.3 to 0.7 port, which is considerably lower than that of the first embodiment, and thus even if the protection resistance value R is one digit lower, Skin problems in clinical trials were about 5
It was confirmed that only about%. Since the skin treatment tool of the second embodiment has a large area and flexibility, it has a feature that one sheet can cover a wide affected area. In the clinical trial in which this skin treatment device was applied to patients with low back pain, the effective cure rate exceeded 70%.

【0028】第2の実施例に係る、第2の対比例につい
て説明する。比較のために、第2の実施例における保護
抵抗Rを除去し、この部位に錫箔を敷いて導電ペースト
で接着した皮接治療具を作成して、第2の対比例とし
た。これによって、治験を行なったところ、皮膚トラブ
ルは被験者の20%にものぼった。これを要するに、本
発明の第2の実施例は、保護抵抗3を導入することによ
って、通電刺激による皮膚トラブルを、導入前に比べ
て、約1/4に減少させ得たことが明らかである。
The second contrast ratio according to the second embodiment will be described. For comparison, the protective resistance R in the second embodiment was removed, and a skin treatment device in which a tin foil was laid on this portion and adhered with a conductive paste was prepared, and the second comparative example was prepared. As a result, when a clinical trial was conducted, skin troubles were found in 20% of the subjects. In summary, it is clear that the second embodiment of the present invention can reduce the skin trouble due to the electrical stimulation to about 1/4 by introducing the protective resistor 3 compared to before the introduction. .

【0029】本発明の皮接治療具の第3の実施例につい
て説明する。図7は、同第3の実施例の断面図である。
図7において、1は第1の導電性鉱物(導電性鉱物
A)、2は第2の導電性鉱物(導電性鉱物B)、3は保
護抵抗、4は貼着布、5は皮膚である。第3の実施例の
構成部材1〜5は、第1の実施例のそれと同じサイズで
あり、第1の導電性鉱物1と第2の導電性鉱物2との正
負極材料組合せは、第1の実施例のそれと同じである
が、第1の導電性鉱物1は、図示の如く、端面で着磁さ
れている。即ち、第1の導電性鉱物(導電性鉱物A)1
は、直径6mm、厚さ2mm、中央部に高さ3mmの突
起を有する焼結フェライト円盤の突起のある面側に、厚
さ3μmの金メッキ(18K)を施した後、円盤円周の
対向する1組の方向に着磁したものである。磁束密度は
磁極近傍で120Oガウスであった。第2の導電性鉱物
(導電性鉱物B)2は、亜鉛製円環の表面に、酸処理に
よって酸化亜鉛膜を形成して成るものである。保護抵抗
3は、導電性フィラー(添加材)としてのカーボン粉末
を分散して成るエポキシ系樹脂である。
A third embodiment of the skin-contacting treatment tool of the present invention will be described. FIG. 7 is a sectional view of the third embodiment.
In FIG. 7, 1 is a first conductive mineral (conductive mineral A), 2 is a second conductive mineral (conductive mineral B), 3 is a protective resistance, 4 is an adhesive cloth, and 5 is skin. . The constituent members 1 to 5 of the third embodiment have the same size as that of the first embodiment, and the positive and negative electrode material combination of the first conductive mineral 1 and the second conductive mineral 2 is the first. The same as that of the first embodiment, but the first conductive mineral 1 is magnetized at the end face as shown in the figure. That is, the first conductive mineral (conductive mineral A) 1
Is a sintered ferrite disk having a diameter of 6 mm, a thickness of 2 mm, and a height of 3 mm at the center, and the surface of the disk having the projections is plated with gold having a thickness of 3 μm (18K). It is magnetized in one set of directions. The magnetic flux density was 120 O Gauss near the magnetic pole. The second conductive mineral (conductive mineral B) 2 is formed by forming a zinc oxide film on the surface of a zinc ring by acid treatment. The protection resistor 3 is an epoxy resin in which carbon powder as a conductive filler (additive material) is dispersed.

【0030】この皮接治療具を皮接すると、皮膚内で
は、図示した方向に、磁場Hが印加されることになる。
前記した12000ガウスの磁束密度は、生体電池正極
である金(18K)から皮膚内に注入される電子e
及び負極であるn形酸化亜鉛半導体から皮膚内に注入さ
れる正孔hの運動方向に、電磁力を作用させるに充分
な大きさの磁場強度を与える。その結果、皮接した時に
正極から注入される電子は、図示したように紙面背面か
ら手前方向へ、また負極から注入される正孔はその逆方
向へ円運動を描いてシフトする。従って、正極下及び負
極下のキャリア密度が低くなり、その分だけ電極の外側
へ酸化還元領域が広がるため、酸化・還元物質の電極下
蓄積による分極が減少し、長時間皮接によっても起電力
の低下が避けられるという利点がある。
When the skin-contact treatment device is skin-contacted, a magnetic field H is applied in the skin in the direction shown.
The magnetic flux density of 12,000 gauss is the electron e injected into the skin from gold (18K), which is the positive electrode of the bio-cell,
And a magnetic field strength of a magnitude sufficient to exert an electromagnetic force in the movement direction of the holes h + injected into the skin from the n-type zinc oxide semiconductor which is the negative electrode. As a result, the electrons injected from the positive electrode when in contact with the skin shift in the front direction from the back surface of the paper as shown in the figure, and the holes injected from the negative electrode shift in a circular motion in the opposite direction. Therefore, the carrier densities under the positive electrode and under the negative electrode become low, and the redox region expands to the outside of the electrode by that much, so the polarization due to the accumulation of redox substances under the electrode decreases and the electromotive force is generated even after long-term skin contact The advantage is that the decrease of

【0031】第3の実施例の治験結果について説明す
る。第3の実施例の皮接治療具を用いて、男女各年代の
多数の被験者(被験者総数75名)に対する肩コリの治
癒実験を行なった。第1の実施例の場台と同様に、各人
3個ずつ3日間貼着して、著効数と有効数の合計を被験
者総数で除することにより、有効治癒率を算定した。そ
の結果、有効治癒率は、約89%であった。皮膚トラブ
ルは、第2の実施例と同様約に、約5%の低水準に止ま
った。有効治癒率が第1の実施例の場合より高まった原
因として、磁場付与の効果が考えられる。コリや痛みの
治癒をもたらす物理的刺激はこの場合、ツボ圧接効果
(指圧効果)、通電効果、磁気効果の三つが相乗してい
ると考えられる。
The clinical trial results of the third embodiment will be described. Using the skin-care treatment tool of the third example, a shoulder stiffness healing experiment was conducted on a large number of subjects (75 subjects in total) of each age group. Similar to the platform of the first embodiment, each person was applied with 3 pieces for 3 days, and the effective cure rate was calculated by dividing the total of the number of effective responses and the effective number by the total number of subjects. As a result, the effective cure rate was about 89%. The skin trouble remained at a low level of about 5%, which was similar to the second embodiment. The reason why the effective healing rate is higher than that in the case of the first embodiment is considered to be the effect of applying a magnetic field. In this case, it is considered that the physical stimuli that bring about healing of stiffness and pain are synergistically composed of the acupoint pressure contact effect (acupressure effect), the energization effect, and the magnetic effect.

【0032】そこで、比較のために、市販の磁気治療器
(磁束密度1200ガウス)を用いて、同じ被験者によ
る皮接テスト(肩コリ治療)を行なった。この場合も、
3ケ/人、3日間貼着して治癒結果を調べた。この結
果、有効治癒率は約37%であった。上記三つの物理刺
激が単純に一次結合して治癒効果を示すものと考える
と、以上の治験データから治癒効果に与える各物理刺激
の寄与は、指圧効果分が34.5%、通電効果分が5
7.5%、磁気効果分が8%となる。
Therefore, for comparison, a skin contact test (shoulder stiffness treatment) was conducted by the same subject using a commercially available magnetic therapy device (flux density 1200 gauss). Also in this case,
3 pieces / person, 3 days affixed and examined the healing result. As a result, the effective cure rate was about 37%. Considering that the above three physical stimuli simply combine linearly to show a healing effect, the contribution of each physical stimulus to the healing effect from the above clinical trial data is that the acupressure effect component is 34.5% and the energization effect component is 5
It is 7.5% and the magnetic effect is 8%.

【0032】本発明の皮接治療具の第4の実施例につい
て説明する。第4の実施例は、第1の実施例を一般化し
たものである。第4の実施例の皮接治療具は、第1の導
電性鉱物と第2の導電性鉱物と保護抵抗とから成り、第
1の導電性鉱物又は第2の導電性鉱物の何れか一方は、
皮接部と導電部とから成り、前記皮接部の皮接面と該皮
接面に速なる導電部表面との間には、段差が設けられ、
前記何れか一方の導電性鉱物の前記導電部と前記保護抵
抗と他方の導電性鉱物とはこの順で積層され、且つ機械
的、電気的に接続され、前記何れか一方の導電性鉱物の
前記皮接部と、前記他方の導電性鉱物とは、同時に皮接
して用いられる。第4の実施例のその余の事項は、第1
の実施例と同様である。
A fourth embodiment of the skin-contacting treatment tool of the present invention will be described. The fourth embodiment is a generalization of the first embodiment. The skin treatment implement of the fourth embodiment comprises a first conductive mineral, a second conductive mineral, and a protective resistor, and either one of the first conductive mineral and the second conductive mineral is ,
A skin contact part and a conductive part, and a step is provided between the skin contact surface of the skin contact part and the conductive part surface accelerating to the skin contact surface,
The conductive portion of the one of the conductive minerals and the protective resistance and the other conductive minerals are laminated in this order, and mechanically and electrically connected, the one of the conductive minerals of the above The skin contact part and the other conductive mineral are used in skin contact at the same time. The remaining matters of the fourth embodiment are the first
This is the same as the embodiment.

【0033】本発明のその他の実施例について説明す
る。 (イ)第1の導電性鉱物1は、少なくとも皮接面が、前
記した金Au及びその合金、ロジウムRhなどの他、白
金Pt、イリジウムIr、パラジウムPd、銀Agやこ
れらを含む合金を用いることが出来る。原理的には、貴
金属以外の標準単極電位の高い金属、例えば銅Cuを用
いることも勿論可能であるが、酸化し易いため、長期連
用には耐え得ない。 (ロ)第2の導電性鉱物2は、少なくとも皮接面が、前
記した酸化亜鉛ZnOや酸化錫SnO以外のM酸化物半
導体、例えば酸化インジウムInや酸化ビスマス
Bi、酸素欠損酸化アルミニウムAl3−x
等であっても良いし、非酸化物のn形半導体、例えばn
−Geや、n−SiC等であっても良い。
Another embodiment of the present invention will be described. (A) For the first conductive mineral 1, at least the skin contact surface is made of platinum Pt, iridium Ir, palladium Pd, silver Ag, or an alloy containing these, in addition to the gold Au and its alloy, rhodium Rh, and the like. You can In principle, it is of course possible to use a metal having a high standard single-pole potential other than a noble metal, for example, copper Cu, but it is difficult to withstand long-term continuous use because it is easily oxidized. (B) At least the skin contact surface of the second conductive mineral 2 is an M oxide semiconductor other than the above-mentioned zinc oxide ZnO and tin oxide SnO, such as indium oxide In 2 O 3 , bismuth oxide Bi 2 O 3 , and oxygen. Defective aluminum oxide Al 2 O 3-x
Etc., or a non-oxide n-type semiconductor, for example, n
It may be -Ge or n-SiC.

【0033】(ハ)保護抵抗3は、導電性フィラー分散
樹脂以外に導電性高分子層を用いることも出来るし、或
は無機抵抗を用いることも可能である。 (ニ)保護抵抗3は、また、両端に印加される電圧によ
って抵抗値が可変となる材料、例えば導電性をもつ液晶
を電極板に挟んで用いることなども可能である。このよ
うな可変抵抗は、生体電池の作用で皮下組織が生理活性
化し、皮膚インピーダンスRや接触抵抗Rが急激に
低下した時、生体電池の外部回路取出し電圧が高くなる
のに対応して抵抗値を大にする機能をもたせると、皮下
組織が不活性な場合(コリや痛みがある場合)は低抵抗
で大電流が流れ、コリや痛みが治癒すると高抵抗化して
通電電流を抑えることが出来るので、保護抵抗値Rとし
てより好ましい。 (ホ)保護抵抗3の適正抵抗値Rは、正極材料と負極材
料の組合せによっても異なるが、皮膚インピーダンスの
大きさと皮接実験データから経験的に割り出された値と
して、0.1〜50MΩの間の適当な値を選べば良い。
以上の実施例は、本発明の精神の範囲内において、種々
なる改変を施すことが出来る。従って、本発明の範囲
は、これらの実施例に止まるものではない。
(C) For the protective resistor 3, a conductive polymer layer can be used in addition to the conductive filler-dispersed resin, or an inorganic resistor can be used. (D) The protective resistor 3 can also be made of a material whose resistance value is variable depending on the voltage applied to both ends, such as a conductive liquid crystal sandwiched between electrode plates. Such a variable resistance corresponds to the fact that when the subcutaneous tissue is physiologically activated by the action of the bio-cell and the skin impedance R S and the contact resistance R C are rapidly reduced, the voltage taken out of the external circuit of the bio-cell becomes high. When the function to increase the resistance value is provided, a large current flows with low resistance when the subcutaneous tissue is inactive (when there is stiffness or pain), and when the stiffness or pain is healed, the resistance increases and the conduction current is suppressed. Therefore, the protection resistance value R is more preferable. (E) The appropriate resistance value R of the protective resistor 3 varies depending on the combination of the positive electrode material and the negative electrode material, but is 0.1 to 50 MΩ as a value empirically determined from the size of the skin impedance and the skin contact test data. You can choose an appropriate value between.
The above examples can be modified in various ways within the spirit of the present invention. Therefore, the scope of the invention is not limited to these examples.

【0034】[0034]

【発明の効果】以上説明したように、本発明によれば、
生体電池皮接治療具の長時間皮接によって、コリや痛み
の治癒の結果発生する皮膚インピーダンスの急激な低下
に起因して惹起される発赤や掻痒感等の皮膚トラブル
を、低率に抑制することが可能になった。そのために、
高起電力を生ずる正極材料と負極材料の組合せの選択が
可能となり、コリや痛みの治療に、より効果的な皮接治
療具を提供することが可能となった。また、金属の表面
処理による酸化物薄膜半導体負極の形成を利用して、安
価でディスポーザブルな皮接治療具の提供が可能になっ
た。
As described above, according to the present invention,
Suppresses skin troubles such as redness and pruritus caused by a sharp decrease in skin impedance resulting from healing of stiffness and pain by long-term skin contact with a bio-battery skin therapeutic device at a low rate It has become possible. for that reason,
It has become possible to select a combination of a positive electrode material and a negative electrode material that generate high electromotive force, and it has become possible to provide a more effective skin treatment tool for treating stiffness and pain. Moreover, it has become possible to provide an inexpensive and disposable skin treatment device by utilizing the formation of an oxide thin film semiconductor negative electrode by surface treatment of a metal.

【図面の簡単な説明】[Brief description of drawings]

【図1】半導体の負極を使用した生体発電皮接治療具の
等価回路を示す図である。
FIG. 1 is a diagram showing an equivalent circuit of a bioelectrical power generation skin treatment implement using a semiconductor negative electrode.

【図2】同生体発電皮接治療具の動作原理を説明するた
めの図である。
FIG. 2 is a view for explaining the operating principle of the bioelectrical skin treatment device.

【図3】本発明の皮接治療具の等価回路を示す図であ
る。
FIG. 3 is a diagram showing an equivalent circuit of a skin treatment implement of the present invention.

【図4】本発明の皮接治療具の動作原理を説明するため
の図である。
FIG. 4 is a view for explaining the operating principle of the skin treatment implement of the present invention.

【図5】本発明の皮接治療具の第1の実施例の断面図で
ある。
FIG. 5 is a sectional view of the first embodiment of the skin treatment implement of the present invention.

【図6】同第2の実施例の構成を示す図である。FIG. 6 is a diagram showing a configuration of the second exemplary embodiment.

【図7】同第3の実施例の断面図である。FIG. 7 is a sectional view of the third embodiment.

【符号の説明】[Explanation of symbols]

1 第1の導電性鉱物(導電性鉱物A) 1 突起 2 第2の導電性鉱物(導電性鉱物B) 3 保護抵抗 4 絆創膏又は貼着布 5 皮膚1 1st electroconductive mineral (electroconductive mineral A) 1 r protrusion 2 2nd electroconductive mineral (electroconductive mineral B) 3 protection resistance 4 adhesive plaster or adhesive cloth 5 skin

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 第1の導電性鉱物(1)と、第2の導電
性鉱物(2)と、保護抵抗(3)とから成り、 前記第1の導電性鉱物(1)は、少なくともその皮接面
が、貴金属又はその合金から成る第1の皮接物質で構成
され、 前記第2の導電性鉱物(2)は、少なくとも皮接面が、
n型半導体から成る第2の皮接物質で構成され、 前記第1の皮接物質と前記第2の皮接物質との組合せ
は、前記第1の皮接物質の標準単極電位が前記第2の皮
接物質のそれよりも高く成るように、或は前記第2の皮
接物質の標準単極電位が前記第1の皮接物質のそれより
も低く成るように選択され、 前記第1の導電性鉱物(1)と前記第2の導電性鉱物
(2)とは、互いに近接して配置され、互いの非皮接領
域において、前記保護抵抗(3)を介して電気的に接続
され、 前記保護抵抗(3)の抵抗値(R)は、0.1〜50M
Ωの範囲から、前記第1、第2の皮接物質の組合せに基
づく起電力に応じて、適当な値が選択され、 前記第1の導電性鉱物(1)と前記第2の導電性鉱物
(2)とは、同時に皮接して用いられる皮接治療具。
1. A first conductive mineral (1), a second conductive mineral (2), and a protective resistance (3), wherein the first conductive mineral (1) is at least the same. The skin-contacting surface is composed of a first skin-contacting material made of a noble metal or an alloy thereof, and the second conductive mineral (2) has at least a skin-contacting surface,
A combination of the first skin-coating material and the second skin-coating material is composed of a second skin-coating material composed of an n-type semiconductor, and the standard monopolar potential of the first skin-coating material is the first 2 is selected to be higher than that of the second skin-coating material, or the standard monopolar potential of the second skin-coating material is lower than that of the first skin-coating material; The conductive mineral (1) and the second conductive mineral (2) are arranged close to each other and electrically connected to each other in the non-skin contact area through the protective resistor (3). The resistance value (R) of the protection resistor (3) is 0.1 to 50M.
An appropriate value is selected from the range of Ω according to the electromotive force based on the combination of the first and second skin contact substances, and the first conductive mineral (1) and the second conductive mineral (2) is a skin-contact therapeutic device that is used by skin-contacting at the same time.
【請求項2】 前記保護抵抗(3)は、導電性フィラー
を分散した樹脂から成り、且つ前記第1の導電性鉱物
(1)と前記第2の導電性鉱物(2)とは、前記樹脂に
よって接着されることにより、電気的に相接続されてい
る、請求項1記載の皮接治療具。
2. The protective resistance (3) is made of a resin in which a conductive filler is dispersed, and the first conductive mineral (1) and the second conductive mineral (2) are the resin. The skin-contacting treatment tool according to claim 1, wherein the skin-contacting treatment tool is electrically phase-connected by being adhered by.
【請求項3】 前記第2の皮接物質は、酸化物半導体で
あり、前記第2の導電性鉱物(2)は、該酸化物半導体
を構成する金属元素を含んでいる、請求項1又は2記載
の皮接治療具。
3. The first skin contact material is an oxide semiconductor, and the second conductive mineral (2) contains a metal element forming the oxide semiconductor. 2. The skin-care treatment tool according to 2.
【請求項4】 皮接時に前記第1の皮接物質より皮膚内
に注入された電子及び前記第2の皮接物質より皮膚内に
注入された正孔の運動に影響を及ぼす程度の強さの磁場
が付与されている、請求項1乃至3の何れかに記載の皮
接治療具。
4. A strength that affects the movement of electrons injected into the skin from the first skin contact material and holes injected into the skin from the second skin contact material during skin contact. The skin treatment tool according to any one of claims 1 to 3, wherein the magnetic field is applied.
【請求項5】 前記第1の導電性鉱物(1)又は前記第
2の導電性鉱物(2)の何れか一方は、皮接部と導電部
とから成り、 該皮接部と該導電部との間には、段差が設けられ、 前記何れかー方の導電性鉱物の前記導電部と前記保護抵
抗(3)と他方の導電性鉱物とはこの順で積層され、且
つ機械的、電気的に接続され、 前記何れか一方の導電性鉱物の皮接部と、前記他方の導
電性鉱物とは、同時に皮接せしめられる、 請求項1乃至4の何れかに記載の皮接治療具。
5. The first conductive mineral (1) or the second conductive mineral (2) comprises a skin contact portion and a conductive portion, and the skin contact portion and the conductive portion. A step is provided between the conductive part, the conductive part of the conductive mineral, the protective resistance (3), and the other conductive mineral, which are laminated in this order, and mechanically and electrically. The skin-contacting treatment tool according to any one of claims 1 to 4, wherein the skin-contacting part of any one of the conductive minerals and the other conductive mineral are simultaneously skin-contacted.
【請求項6】 前記第1の導電性鉱物(1)が、皮接部
と導電部とから成り、 前記皮接部は、盤体の略中央部に位置する突起(1r)
から成り、 前記導電部は、前記盤体の突起(1r)以外の部分から
成り、 前記第2の導電性鉱物(2)及び前記保護抵抗(3)に
はそれぞれ、貫通孔が設けられ、 前記第1の導電性鉱物(1)と前記第2の導電性鉱物
(2)と前記保護抵抗(3)とは、前記第1の導電性鉱
物(1)の前記皮接部が前記保護抵抗(3)の貫通孔と
前記第2の導電性鉱物の貫通孔とを貫通して突出するよ
うに、且つ、前記第1の導電性鉱物(1)の前記導電部
と前記保護抵抗(3)の殆ど全部と前記第2の導電性鉱
物(2)の殆ど全部とがこの順で積層されるように、配
置されている請求項5記載の皮接治療具。
6. The first conductive mineral (1) is composed of a skin contact portion and a conductive portion, and the skin contact portion is a protrusion (1r) located at a substantially central portion of the board.
The conductive portion is formed of a portion other than the protrusion (1r) of the board, and a through hole is provided in each of the second conductive mineral (2) and the protective resistor (3), In the first conductive mineral (1), the second conductive mineral (2), and the protective resistance (3), the skin contact portion of the first conductive mineral (1) is the protective resistance ( 3) so as to penetrate through the through hole of 3) and the through hole of the second conductive mineral, and to project the conductive portion of the first conductive mineral (1) and the protective resistance (3). The skin contact treatment tool according to claim 5, wherein almost all and almost all of the second conductive mineral (2) are arranged so as to be stacked in this order.
JP34084194A 1994-12-22 1994-12-22 Skin contact device Expired - Lifetime JP3748278B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34084194A JP3748278B2 (en) 1994-12-22 1994-12-22 Skin contact device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34084194A JP3748278B2 (en) 1994-12-22 1994-12-22 Skin contact device

Publications (2)

Publication Number Publication Date
JPH08173554A true JPH08173554A (en) 1996-07-09
JP3748278B2 JP3748278B2 (en) 2006-02-22

Family

ID=18340802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34084194A Expired - Lifetime JP3748278B2 (en) 1994-12-22 1994-12-22 Skin contact device

Country Status (1)

Country Link
JP (1) JP3748278B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0894508A3 (en) * 1997-07-31 2000-01-12 Kabushiki Kaisha Bangahdo Skin-contact type medical treatment apparatus
US6083253A (en) * 1997-06-26 2000-07-04 Ogama; Kenji Skin-contact type medical treatment apparatus
AU2010260490B2 (en) * 2009-06-15 2012-10-11 Elc Management Llc Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
WO2013183695A1 (en) * 2012-06-08 2013-12-12 株式会社ポリトロニクス Method and apparatus for proliferation and activation of fibroblast
US9566430B2 (en) 2008-04-23 2017-02-14 Elc Management Llc Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
WO2022085697A1 (en) * 2020-10-21 2022-04-28 トライポッド・デザイン株式会社 Device and energization method

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6153259B2 (en) * 2013-07-12 2017-06-28 賢司 小蒲 Biological battery treatment tool
JP5966108B1 (en) * 2016-02-29 2016-08-10 株式会社ポリトロニクス Skin contact treatment device and energizing tip used therefor
JP6006900B1 (en) * 2016-07-04 2016-10-12 株式会社ポリトロニクス Skin contact treatment device and energizing tip used therefor

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083253A (en) * 1997-06-26 2000-07-04 Ogama; Kenji Skin-contact type medical treatment apparatus
EP0894508A3 (en) * 1997-07-31 2000-01-12 Kabushiki Kaisha Bangahdo Skin-contact type medical treatment apparatus
US6044286A (en) * 1997-07-31 2000-03-28 Kabushiki Kaisha Bangahdo Skin-contact type medical treatment apparatus
US9566430B2 (en) 2008-04-23 2017-02-14 Elc Management Llc Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
AU2010260490B2 (en) * 2009-06-15 2012-10-11 Elc Management Llc Microcurrent-generating topical or cosmetic systems, and methods of making and using the same
WO2013183695A1 (en) * 2012-06-08 2013-12-12 株式会社ポリトロニクス Method and apparatus for proliferation and activation of fibroblast
JP2013252117A (en) * 2012-06-08 2013-12-19 Polytronics Ltd Method and apparatus for proliferation and activation of fibroblast
WO2022085697A1 (en) * 2020-10-21 2022-04-28 トライポッド・デザイン株式会社 Device and energization method

Also Published As

Publication number Publication date
JP3748278B2 (en) 2006-02-22

Similar Documents

Publication Publication Date Title
US5772688A (en) Skin-contact type medical treatment apparatus
US5944685A (en) Skin-contact type medical treatment apparatus
EP0788810B1 (en) Skin-contact type medical treatment apparatus
US7643874B2 (en) Dermal patch
US4211222A (en) Iontophoretic burn-protection method
JP2007504882A (en) Disposable electric bandage
JP2005506158A (en) Transdermal patch
KR20110118647A (en) Methods for reducing discomfort during electrostimulation, and compositions and apparatus therefor
JPH08173554A (en) Skin contact therapeutic apparatus
JPH01280476A (en) Apparatus and method for minimizing skin damage generated by electrode
US9037269B2 (en) Applicator head and method for treatment of pain by transcutaneous electrical nerve stimulation
CN2930747Y (en) Electrical ion medicament plaster
GB2030453A (en) Applying undirectional electric current to the skin of a living body
CN109431788A (en) A kind of galvanic corrosion acupuncture needle
DE19854290C2 (en) Physiotherapy mat for skin irritation and blood circulation with stimulation current
RU2146122C1 (en) Applicator
JP3566346B2 (en) Transdermal drug delivery device
JPH0316573A (en) Element for percutaneous administration
JP6725124B1 (en) Bio battery treatment tool
WO2023234145A1 (en) Transdermal current-carrying patch
JP6789469B1 (en) Bio-battery treatment tool
JP7422810B2 (en) transdermal energizing patch
CN215193735U (en) Thumb-tack needle
KR20010070120A (en) Skin contact type Aluminum medical implement
JP2002345977A (en) Ion introduction tool

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20041129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041207

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20050223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050510

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050711

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20051125

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091209

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091209

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101209

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101209

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111209

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111209

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121209

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121209

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131209

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term